Novel Biomedical Agents from Plants

Biotechnological Production of Plant Secondary Metabolites

Volumn , Issue , 2012, Pages 53-66

  Ata, Athar ^a  

^a UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

glucosidase; Acetylcholinesterase; Bioactivity; Biosynthesis; Enzyme inhibition; Glutathione s transferase; Isolation; Natural products; Pharmacophore; Phytochemistry

Indexed keywords

EID: 84882754203     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805114411201010053     Document Type: Chapter

References (56)

1. McChesney JD, Venkataraman SK, Henri JT. Plant natural products: Back to the future or into extinction? Phytochemistry 2007; 68: 2015-22.
2. Newman DJ, Cragg GM. Natural products as source of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-77.
3. Newman DJ, Craig GM, Sanderb KM. The influence of natural products upon drug discovery. Nat Prod Rep 2000; 17: 215-34.
4. Ata A. In: Sener B, Ed. Innovations in Chemical Biology. New York, Springer 2009; pp. 51-60.
5. Ata A, Van Den Bosch SA, Harwanik DJ, Pidsinski GE. Gluthathione S-transferase and acetylcholinesterase inhibiting natural products from medicinally important plants. Pure Appl Chem 2007; 70: 2269-76.
6. Ata A, Udenigwe CC. The discovery and application of inhibitors of glutathione S-transferase as therapeutic agents -a review. Curr Bioactive Compds 2008; 4: 41-50.
7. Ata A, Diduck C, Udenigwe CC, Zahid S, Decken A. New chemical constituents of Ambrosia psilostachya. ARKIVOC 2007; 13: 195-203.
8. Douglas KT. Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol 1987; 59: 103-67.
9. Adang AE, Brussee J, Gen A van der, Mulder GJ. The glutathione binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and gamma-glutamyl domains. Biochem J 1990; 269: 47-54.
10. Abramovitz M, Homma H, Ishigaki S, Tansey F, Cammer W, Listowsky I. Characterization and localization of glutathione- S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 1988; 50: 50-57.
11. Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, Tew KD. Characterization of glutathione Stransferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res 1990; 50: 3562-68.
12. Ata A, Gale EM, Samarasekera R. Bioactive chemical constituents of Caesalpinia bonduc (Fabaceae). Phytochem Lett 2009; 2: 106-9.
13. Ata A, Udenigwe CC, Gale EM, Samarasekera R. Minor chemical constituents of Caesalpinia bonduc. Nat Prod Comm 2009; 4: 311-14.
14. Udenigwe CC, Ata A, Samarasekera R. Glutathione S-transferase inhibiting chemical constituents of Caesalpinia bonduc. Chem Pharm Bull 2007; 55: 442-45.
15. Iverson CD, Zahid S, Li Y, Shoqafi AH, Ata A, Samarasekera R. Glutathione S-transferase inhibitory, free radical scavenging, and anti-leishmanial activities of chemical constituents of Artocarpus nobilis and Matricaria chamomilla. Phytochem Lett 2010; 3: 207-11.
16. Ata A, Udenigwe CC, Matochko W, Holloway P, Eze MO, Uzoegwu, PN. Chemical constituents of Nauclea latifolia and their anti-GST and anti-fungal activities. Nat Prod Comm 2009; 4: 1185-88.
17. Ata A, Kalhari KS, Samarasekera R. Chemical constituents of Barleria prionitis and their enzyme inhibitory and free radical scavenging activities. Phytochem Lett 2009; 2: 37-40.
18. Ata A, Conci LJ, Orhan I. Mucoralactone A: an unusual steroid from the liquid culture of Mucor plumbeus. Heterocycles 2006; 68: 2097-2106.
19. Rosenberry TL. Acetylcholinesterase. Adv Enzymol Relat Areas Mol Biol 1975; 43: 103-218.
20. Enz A, Amstutz R, Boddeke H, Gmelin G, Malonowski J. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res 1993; 98: 431-45.
21. Fang L, Chen Y, Zhang Y. Advances in the researches on cholinesterase inhibitors for the treatment of Alzheimer's disease. Yaoxue Jinzhan 2009; 33: 289-96.
22. Tumiatti V, Minarini A, Bolognesi ML, Milelli A, Rosini M, Melchiorre C. Tacrine derivatives and Alzheimer's disease. Curr Med Chem 2010; 17: 1825-38.
23. Ribeiz SRI, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CMC. Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. CNS Drugs 2010; 24: 303-17.
24. Heinrich M. In Cordell GA, Ed. Alkaloids. San Diego, CA, Elsevier. 2010; pp. 157-65.
25. Liepelt I, Gaenslen A, Godau J, et al. Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis. Alzheimers Demen 2010; 6: 70-74.
26. Galisteo M, Rissel M, Sergent O, et al. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation. J Pharmacol Exp Ther 2000; 294: 160-67.
27. Grossberg GT, Stahelin HB, Messina JC, Anand R. Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications. Int J Geriatr Psychiatry 2000; 15: 242-47.
28. Kaur J, Zhang M-Q. Molecular modelling and QSAR of reversible acetylcholinesterase inhibitors. Curr Med Chem 2000; 7: 273-94.
29. Di Giovanni S, Borloz A, Urbain A et al. In-vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: Thin layer chromatography versus microplate methods. Eur J Pharm Sci 2008; 33: 109-19.
30. Ge HM, Zhu CH, Shi DH, et al. Hopeahainol A: An acetylcholinesterase inhibitor from Hopea hainanensis. Chem Eur J 2008; 14: 376-81.
31. Berkov S, Codina C, Viladomat F, Bastida J. N - Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorg Med Chem Lett 2008; 18: 2263-66.
32. Wen H, Lin C, Ling Q, et al. Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors. Eur J Med Chem 2008: 43:166-73.
33. Halldorsdottir ES, Jaroszewski JW, Olafsdottir ES. Acetylcholinesterase inhibitory activity of lycopodane-type alkaloids from the Icelandic Lycopodium annotinum ssp. alpestre. Phytochemistry 2010; 71: 149-57.
34. Huang L, Luo Z, He F, Lu J, Li X. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Bioorg Med Chem 2010; 18: 4475-84.
35. Babar ZU, Ata A, Meshkatalsadat MH. New bioactive steroidal alkaloids from Buxus hyrcana. Steroids 2006; 71: 1045-51.
36. Choudhary MI, Shahnaz S, Parveen S, et al. New triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana. J Nat Prod 2003; 66: 739-42.
37. Atta-ur-Rahman, Choudhary MI. Recent studies on bioactive natural products. Pure Appl Chem 1999; 71: 1079-1081.
38. Atta-ur-Rahman, Parveen S, Khalid A, Farooq A, Ayattollahi SAM, Choudhary MI. Acetylcholinesterase inhibiting triterpenoidal alkaloids from Buxus hyrcana. Heterocycles 1998; 49: 481-88.
39. Sauvaitre T, Barlier M., Herlem D, et al. New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series. J Med Chem 2007; 50: 5311-23.
40. Corry DB, Tuck ML. Protection from vascular risk in diabetic hypertension. Curr Hypertens Resp 2000; 2: 154-59.
41. Ata A, Tan DS, Matochko WL, Adesanwo JK. Chemical constituents of Drypetes gossweileri and their enzyme inhibitory and anti-fungal activities. Phytochem Lett 2011; 4: 34-37.
42. Atta-ur-Rahman, Choudhary MI, Basha FZ, Abbad G, Khan SN, Shah SAA. Sciences at the interface of chemistry and biology: Discoveries of α-glucosidase inhibitors and antiglycation agents. Pure Appl Chem 2007; 70; 2263-68.
43. Phuwapraisirisan P, Puksasook T, Jong-aramruang J, Kokpol U. Phenylethyl cinnamides: A new series of α-glucosidase inhibitors from the leaves of Aegle marmelos. Bioorg Med Chem Lett 2008; 18: 4956-58.
44. Tabopda TK, Ngoupayo J, Liu J, et al. α-Glucosidase inhibitors ellagic acid derivatives with immunoinhibitory properties from Terminalia superba. Chem Pharm Bull 2008; 56: 847-50.
45. Gao H, Huang Y-N, Gao B, Kawabata J. Chebulagic acid is a potent α -glucosidase inhibitor. Biosci Biotech Biochem 2008; 72: 601-3.
46. Zhang L, Wang Y, Wang Z. Research on method for synthesis of salacinol, a natural antidiabetic drug. Huagong Shikan 2008; 22: 42-44.
47. Choubdar N, Bhat, RG, Stubbs KA, Yuzwa S, Pinto BM. Synthesis of 2-amido, 2-amino, and 2-azido derivatives of the nitrogen analog of the naturally occurring glycosidase inhibitor salacinol and their inhibitory activities against OGlcNAcase and NagZ enzymes. Carbohydrate Res 2008; 343:1766-77.
48. Sim L, Jayakanthan K, Mohan S, et al. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: Structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Biochemistry 2010; 49: 443-51.
49. Ozaki S, Oe H, Kitamura S. α -Glucosidase inhibitor from kothala-himbutu (Salacia reticulata WIGHT). J Nat. Prod 2008; 71: 981-84.
50. Hou W, Li Y, Zhang Q, et al. Triterpene acids isolated from Lagerstroemia speciosa leaves as α-glucosidase inhibitors. Phytother Res 2009; 23: 614-18.
51. Ngoupayo J, Tabopda, Turibio K, Ali MS,Tsamo E. α -Glucosidase inhibitors from Garcinia brevipedicellata (Clusiaceae). Chem Pharm Bull 2008; 56: 1466-69.
52. Reddy PP, Tiwari, AK, Rao RR, et al. New Labdane diterpenes as intestinal α - glucosidase inhibitor from antihyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes. Bioorg Med Chem Lett 2009; 19: 2562-65.
53. Aparna P, Tiwari AK, Srinivas PV, Ali AZ, Anuradha V, Rao JM. Dolichandroside A, A new α -glucosidase inhibitor and DPPH free-radical scavenger from Dolichandrone falcata Seem. Phytother Res 2009; 23: 591-96.
54. Dewick PM. Biosynthesis of the 3-benzylchroman-4-one eucomin in Euconis bicolor. Phytochemistry 1975; 14: 983-88.
55. Dewick PM, Baz W, Grisebach H. Biosynthesis of coumestrol in Phaseolus aureous Phytochemistry 1970; 9: 775-83.
56. Nguyen A-T, Fontaine J, Malonne H, Duez P. Homoisoflavanones from Disporopsis aspera. Phytochemistry 2006; 67:2159-63.